Dedication celebrates new Drug Discovery, Bindley Multidisciplinary Cancer Research facilities
September 5, 2014

Purdue University marked the opening of new Discovery Park interdisciplinary research facilities in drug development and cancer, key components of the Purdue Moves initiative, during a dedication ceremony on Friday (Sept. 5).

Purdue to mark opening of new cancer buildings
September 3, 2014

Purdue University is planning a ceremony to mark the opening of a nearly $29 million facility that will consolidate drug research centers at the school and a $16 million expansion of a cancer research center.

Purdue University researchers study ways to kill MERS virus
May 2, 2014

The fight against the MERS virus has some Hoosier backing. Researchers at Purdue University showed off a prototype drug molecule that demonstrates what they're doing to hopefully keep it from spreading, and keep you protected. Those same researchers have been working on finding ways to stop MERS from spreading well before it showed up in Indiana.

Neuro Vigor licenses innovative Purdue technology to treat neurological diseases
April 24, 2014

Neuro Vigor LLC announced Thursday (April 24) the signing of an exclusive worldwide license with Purdue Research Foundation to develop and commercialize technology that promises an innovative approach to reducing the symptoms and pain of neurological disease and injury, including multiple sclerosis, neuropathic pain and Parkinson's disease.

Purdue discovery leads to Endocyte drug that receives positive opinion from EU regulatory body
March 21, 2014

A cancer targeting innovation discovered more than two decades ago by a Purdue University professor of chemistry and his then-graduate research assistant could be closer to benefiting patients with ovarian and lung cancers and other diseases after receiving positive opinions from clinical trials conducted in the U.S. and Europe.

Purdue, Houston Methodist partner to take drug discoveries from the 'bench top to the bedside'
March 13, 2014

Purdue University and Houston Methodist Research Institute plan to collaborate on research and educational initiatives, including clinical trials of drugs developed at Purdue. The partnership helps to advance the Purdue Moves drug discovery initiative to translate basic research into life-changing treatments.

Divergent Total Syntheses of LyconadinsA and C
March 5, 2014

Divergent and concise total syntheses of two lycopodium alkaloids, lyconadins A and C have been developed. The synthesis of lyconadin A, having potent neurotrophic activity, features an efficient one-pot ketal removal and formal aza-[4+2] cyclization to form the cagelike core structure. A tandem ketal removal/Mannich reaction was developed to build the tricyclic structure of lyconadin C. Both lyconadins A and C were synthesized from a pivotal intermediate.

R. Graham Cooks Awarded 2013 Dreyfus Prize
May 23, 2013

R. Graham Cooks, the Henry Bohn Hass Distinguished Professor of Chemistry at Purdue University, is the recipient of the 2013 Dreyfus Prize in the Chemical Sciences, conferred this year in chemical instrumentation. He will be formally honored this fall at Purdue University with a $250,000 prize and a medal. An innovative giant in the field of mass spectrometry, Cooks has enriched analytical chemistry in unparalleled ways. Among their accomplishments, Cooks and his team have created miniature mass spectrometers, enabling their remote deployment even under battery power. Once roughly as large as automobiles, mass spectrometers now are available in sizes as small as shoeboxes, allowing their widespread use in clinics, homeland security, the military and food safety.

Professors new chemistry toolbox licensed to Sigma-Aldrich
May 13, 2013

Prof. David A. Colby's safer, easier and "greener" method to incorporate fluorine into organic compounds - a common step in materials processing, drug discovery and synthesis of agricultural treatments - has been licensed to a subsidiary of Sigma-Aldrich Corporation, a St. Louis-based life science and high technology company. Colby, an assistant professor of medicinal chemistry and organic chemistry, developed a chemical reagent that safely makes fluorine available during the creation of a new chemical compound. The reagent could provide drug manufacturers an improved method for using fluorine in the drug discovery process and enhance large-scale production of drugs for pharmaceutical manufacturers.

Bird flu expert working on vaccine that protects against multiple strains
May 5, 2013

As the H7N9 avian influenza outbreak in China worsens, Prof. Suresh Mittal is working on vaccines that offer broader protection against multiple strains of the virus. "Avian influenza viruses are moving targets that rapidly evolve and evade vaccines that are specific to a predicted strain," says Mittal, who created vaccines for past strains of bird flu and continues to collaborate with the Centers for Disease Control and Prevention. "We need a vaccine that protects against a spectrum of strains to prepare for a potential pandemic. Such a vaccine may not offer full protection from the strain that pops up, but even partial protection could save lives and buy time to create a more effective vaccine."